FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1.

Mouron S, Manso L, Caleiras E, Rodriguez-Peralto JL, Rueda OM, Caldas C, Colomer R, Quintela-Fandino M, Bueno MJ
Breast Cancer Res. 2021 Feb 12;23(1):21. doi: 10.1186/s13058-021-01398-8. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.